PECULIARITIES OF THE DIAGNOSIS AND TREATMENT OF INFERTILITY IN MEN WITH OBESITY


Cite item

Full Text

Abstract

There are more than 17% of infertile couples in Russia, and this figure tends to increase. About half of cases of infertility are caused by male infertility. Infertility is idiopathic in 31 to 75% of men. These patients are mainly empirically treated using drugs of different groups (antiestrogen, aromatase inhibitors, luteinizing hormone, follicle-stimulating hormone, gonadotropin-releasing hormone, antioxidants and biologically active dietary supplements, etc.) that are frequently ineffective. As possible, obesity is one of the factors that adversely affect sperm parameters. According to the WHO data (2003), 1.7 billion people worldwide are overweight, a significant portion of them are men of reproductive age. This article discusses the main ways of pathogenesis, diagnosis and treatment of infertility in men with obesity.

Keywords

References

  1. WHO manual for the standardized investigation and diagnosis of the infertile couple. WHO, 3-th ed. Cambridge universiti press 2000;90.
  2. Сухих Г.Т., Божедомов В.А. Мужское бесплодие. М., 2009. C. 7.
  3. Нишлаг Э., Бере Г.М. Андрология. М., 2005. C. 102.
  4. WHO manual for the standardized investigation and diagnosis of the infertile couple. WHO, 3-th ed. Cambridge universiti press, 2000;105.
  5. Демидова Т.Ю., Аметов А.С., Пархонина Е.С. Ожирение - основа метаболического синдрома // Лечащий врач. 2002. № 5. С. 28-31.
  6. Abdel-Halim R.E. Obesity: 1000 years ago. Lancet 2005;366:204.
  7. Avicenna. The disadvantages of excessive weight. In: Avicenna. The canon of medicine, book IV: diseases involving more than one member; the Cosmetic art. Medical Press. 1593:173-74.
  8. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004;291:2847-50.
  9. Magnusdottir EV, Thorsteinsson T, Thorsteinsdottir S, et al. Persistent organochlorines, sedentary occupation, obesity and human male subfertility. Hum Reprod 2005;20:208-15.
  10. Sallmen M, Sandler DP, Hoppin JA, et al. Reduced fertility among overweight and obese men. Epidemiology 2006;17:520-23.
  11. Alavanja MC, Sandler DP, McMaster SB, et al. The Agricultural Health Study. Environ Health Perspect 1996;104:362-9.
  12. Ramlau-Hansen CH, Thulstrup AM, Nohr EA, et al. Subfecundity in overweight and obese couples. Hum Reprod 2007;22:1634-37.
  13. Olsen J, Melbye M, Olsen SF, et al. The Danish National Birth Cohort-its background, structure and aim. Scand J Public Health 2001;29:300-07.
  14. Nguyen R, Wilcox A, Skjaerven R, et al. Men's body mass index and infertility. Hum Reprod 2007;17:2488-93.
  15. Hanafy S, Halawa FA, Mostafa T, et al. Serum leptin correlates in infertile oligozoospermic males. Andrologia 2007;39:177-80.
  16. Zorn B, Osredkar J, Meden-Vrtovec H, et al. Leptin levels in infertile male patients are correlated with inhibin B, testosterone and SHBG but not with sperm characteristics. Int J Androl 2007;30(5),439-44.
  17. Bonde JP, Ernst E, Jensen TK, et al. Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet 1998;352:1172-77.
  18. Guzick DS, Overstreet JW, Factor-Litvak P, et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 2001;345:1388-93.
  19. Slama R, Eustache F, Ducot B, et al. Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum Reprod 2002;17:503-15.
  20. Jensen TK, Andersson AM, Jorgensen N, et al. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril 2004;82:863-70.
  21. Fejes I, Koloszar S, Szollosi J, et al. Is semen quality affected by male body fat distribution? Andrologia 2005;37:155-59.
  22. Kort HI, Massey JB, ElsnerCW, et al. Impact of body mass index values on sperm quantity and quality. J Androl 2006;27:450-52.
  23. Giagulli VA, Kaufman JM, Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. J Clin Endocrinol Metab 1994;79:997-1000.
  24. Tchernof A, Despres JP, Belanger A, et al. Reduced testosterone and adrenal C19 steroid levels in obese men. Metabolism 1995;44:513-19.
  25. Schneider G, Kirschner MA, Berkowitz R, et al. Increased estrogen production in obese men. J Clin Endocrinol Metab 1979;48:633-38.
  26. Akingbemi BT. Estrogen regulation of testicular function. Reprod Biol Endocrinol 2005;3:51.
  27. Cohen PG. The hypogonadal-obesity cycle: role of aromatase in modulating the testosterone-estradiol shunt - a major factor in the genesis of morbid obesity. Med Hypotheses 1999;52(1):49-51.
  28. Marin P, Oden B, Bjorntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 1995;80:239-43.
  29. Kapoor D, Channer KS, Jones TH. Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with Type 2 diabetes. Diabetes Vasc Dis Res 2008;5(2):135-37.
  30. Kaukua J, Pekkarinen T, Sane T, et al. Sex hormones and sexual function in obese men losing weight. Obes Res 2003;11:689-94.
  31. Price TM, O'Brien SN, Welter BH, et al. Oestrogen regulation of adipose tissue lipoprotein lipase-possible mechanisms of body fat distribution. Am J Obstet Gynecol 1998;178:101-07.
  32. de Boer H, Verschoor L, Ruinemans-Koerts J, et al. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. Diabetes Obes Metab 2005;7:211-15.
  33. Pavlovich CP, King P, Goldstein M, et al. Evidence of a treatable endocrinopathy in infertile men. J Urol 2001;165:837-41.
  34. Tsai EC, Matsumoto AM, Fujimoto WY, et al. Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care 2004;27:861-8.
  35. Luboshitzky R, Lavie L, Shen-Orr Z, et al. Altered luteinizing hormone and testosterone secretion in middle-aged obese men with obstructive sleep apnea. Obes Res 2005;13:780-86.
  36. Luboshitzky R, Zabari Z, Shen-Orr Z, et al. Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab 2001;86:1134-39.
  37. Blank DM, Clark RV, Heymsfield SB, et al. Endogenous opioids and hypogonadism in human obesity. Brain Res Bull 1994;34:571-74.
  38. Baccetti B, La Marca A, Piomboni P, et al. Insulin-dependent diabetes in men is associated with hypothalamo-pituitary derangement and with impairment in semen quality. Hum Reprod 2002;17:2673-77.
  39. Agbaje IM, Rogers DA, McVicar CM, et al. Insulin dependant diabetes mellitus: implications for male reproductive function. Hum Reprod 2007;22:1871-77.
  40. Margetic S, Gazzola C, Pegg GG, et al. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002;26:1407-33.
  41. Isidori A, Fabbri A. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 1999;84:3673-80.
  42. Vettor R, De Pergola G, Pagano C, et al. Gender differences in serum leptin in obese people: relationships with testosterone, body fat distribution and insulin sensitivity. Eur J Clin Invest 1997;27:1016-24.
  43. Zorn B, Osredkar J, Meden-Vrtovec H, et al. Leptin levels in infertile male patients are correlated with inhibin B, testosterone and SHBG but not with sperm characteristics. Int J Androl 2007;30(5):439-44.
  44. Hanafy S, Halawa FA, Mostafa T, et al. Serum leptin correlates in infertile oligozoospermic males. Andrologia 2007;39:177-80.
  45. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999;84(10):3686-95.
  46. Strobel A, Issad T, Camoin L, et al. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18:213-15.
  47. Oliva A, Spira A, Multigner L. Contribution of environmental factors to the risk of male infertility. Hum Reprod 2001;16:1768-76.
  48. Sharpe RM. Lifestyle and environmental contribution to male infertility. Br Med Bull 2000;56:630-42.
  49. Jung A, Schill WB. Male infertility. Current life style could be responsible for infertility. MMW Fortschr Med 2000;142:31-3.
  50. Munoz-de-Toro M, Beldomenico HR, Garcia SR, et al. Organochlorine levels in adipose tissue of women from a littoral region of Argentina. Environ Res 2006;102:107-12.
  51. Marin P, Oden B, Bjorntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 1995;80:239-43.
  52. Mieusset R, Bujan LE, Massat G, et al. Inconstant ascending testis as a potential risk factor for spermatogenesis in infertile men with no history of cryptorchism. Hum Reprod 1997;12:974-79.
  53. Bujan L, Daudin M, Charlet JP, et al. Increase in scrotal temperature in car drivers. Hum Reprod 2000;15:1355-57.
  54. Figa-Talamanca I, Cini C, Varricchio GC, et al. Effects of prolonged autovehicle driving on male reproduction function: a study among taxi drivers. Am J Ind Med 1996;30:750-58.
  55. Brindley GS. Deep scrotal temperature and the effect on it of clothing, air temperature, activity, posture and paraplegia. Br J Urol 1982;54:49-55.
  56. Momen MN, Fahmy I, Amer M, et al. Semen parameters in men with spinal cord injury: changes and aetiology. Asian J Androl 2007;9:684-89.
  57. Shafik A, Olfat S. Lipectomy in the treatment of scrotal lipomatosis. Br J Urol 1981;53:55-61.
  58. Jung A, Schill WB. Male infertility. Current life style could be responsible for infertility. MMW Fortschr Med 2000;142:31-3.
  59. Bacon CG, Mittleman MA, Kawachi I, et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003;139:161-68.
  60. Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med 2000;30:328-38.
  61. O'Brien JH, Lazarou S, Deane L, et al. Erectile dysfunction and andropause symptoms in infertile men. J Urol 2005;174:1932-34.
  62. Seftel A. Male hypogonadism. Part II: etiology, pathophysiology, and diagnosis. Int J Impot Res 2006;18:223-28.
  63. Sullivan ME, Thompson CS, Dashwood MR, et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999;43:658-65.
  64. Chung WS, Sohn JH, Park YY. Is obesity an underlying factor in erectile dysfunction? Eur Urol 1999;36:68-70.
  65. Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med 2000;30:328-38.
  66. Brody S. Slimness is associated with greater intercourse and lesser masturbation frequency. J Sex Marital Ther 2004;30:251-61.
  67. Kaukua J, Pekkarinen T, Sane T, et al. Sex hormones and sexual function in obese men losing weight. Obes Res 2003;11:689-94.
  68. Niskanen L, Laaksonen DE, Punnonen K, et al. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes Obes Metab 2004;6:208-15.
  69. Globerman H, Shen-Orr Z, Karnieli E, et al. Inhibin B in men with severe obesity and after weight reduction following gastroplasty. Endocr Res 2005;31:17.
  70. Bastounis EA, Karayiannakis AJ, Syrigos K, et al. Sex hormone changes in morbidly obese patients after vertical banded gastroplasty. Eur Surg Res 1998;30:43-7.
  71. Bacon CG, Mittleman MA, Kawachi I, et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003;139:161-68.
  72. Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004;291:2978-84.
  73. Semple PA, Graham A, Malcolm Y, et al. Hypoxia, depression of testosterone, and impotence in pickwickian syndrome reversed by weight reduction. Br Med J (Clin Res Ed) 1984;289:801-02.
  74. Clark RV, Sherins RJ. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover. J Androl 1989;10:240-47.
  75. Vandekerckhove P, O'Donovan PA, Lilford RJ, et al. Infertility treatment: from cookery to science. The epidemiology of randomised controlled trials. Br J Obstet Gynaecol 1993;100:1005-36.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies